Improving Wound Care Healing through Innovation

Our goal is to improve lives through leading-edge advancements in biomaterials science and medical device technologies.

We are committed to innovating new human keratin-based healthcare technologies in order to provide patients and healthcare providers with active wound care solutions. Cell Constructs specializes in technologies to advance wound healing.

Company History

Cell Constructs is a regenerative healthcare company dedicated to improving wound care healing, leveraging proprietary medical device technologies and biotechnology research and development. There are approximately 350 million people worldwide with diabetes, with up to 90 million people affected in the U.S. and Europe alone. Of these, it’s estimated that 14 million people suffer from chronic wounds annually. Complications from chronic wounds can lead to debilitating and life-threatening complications as well as increased healthcare costs.1 The Company’s first device, ProgenaMatrix™, is an active wound care solution utilizing human keratin. The company was founded in 2008 by experienced scientists from biotechnology and medical device disciplines and is headquartered in Marietta, Georgia, U.S.A.

1. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367-7.

Connect with Us

ProgenaMatrix is currently undergoing a 510k premarket review by FDA for dry, light and moderately exuding partial and full thickness wounds. Not available for sale or other clinical use.

Copyright ©2017, Cell Constructs, LLC. All rights reserved.